Top in cardiology: Lifestyle interventions, causal link between BP and AF risk

Data from the PROPEL trial revealed that a 24-month intensive lifestyle intervention initiated in the primary care setting improved risk factors for patients with obesity. It was the top story in cardiology last week.

Another top story focused on a genetic study done using Mendelian randomization. The results showed a causal link between elevated BP and risk for atrial fibrillation (AF).

Read these and more top stories in cardiology below:

Cardiometabolic health improved by lifestyle interventions in primary care setting

A 24-month lifestyle intervention provided in the primary care setting by health coaches improved cardiometabolic risk factors among patients with obesity compared with usual care alone, according to data published in Circulation. Read more.

Genetic study indicates causal link between elevated BP, AF risk

In a Mendelian randomization study, elevated systolic BP, diastolic BP and pulse pressure were each associated with an increased risk for AF. Read more.

Rural residence tied to increased mortality in HF

Living in a rural area was associated with an elevated mortality rate in patients with heart failure, according to study findings published in the Journal of the American Heart Association. Read more.

Obesity plays major role in new-onset diabetes; relationship varies by race, sex

The prevalence of obesity was associated with a significant uptick in incident diabetes among U.S. adults, with a disparate impact among white women, according to data published in the Journal of the American Heart Association. Read more.

Effects of rivaroxaban plus aspirin consistent regardless of BMI, weight: COMPASS

The effects found with low-dose rivaroxaban (Xarelto, Janssen/Bayer) plus aspirin are consistent regardless of patient BMI and weight, according to research published in the Journal of the American College of Cardiology. Read more.